An American national has tested positive for the Ebola virus in the Democratic Republic of Congo, the Centers for Disease Control and Prevention (CDC) confirmed on Monday. The individual was exposed to the virus through their work in Congo, experienced symptoms over the weekend, and received a positive test result late Sunday, according to Dr. Satish Pillai, the CDC's Ebola response incident manager.
The CDC, in coordination with the State Department, is facilitating the transfer of the infected American, along with six other U.S. citizens who were exposed, to Germany. These individuals will receive specialized treatment, care, and monitoring in Germany. Dr. Pillai emphasized that despite this case, no Ebola cases linked to this specific outbreak have been confirmed within the United States. The overall risk to the American public and international travelers is considered low.
This announcement follows closely on the heels of the World Health Organization's declaration on Sunday of the Ebola epidemic as a "public health emergency of international concern." While the outbreak does not currently meet the criteria for a "pandemic emergency," the WHO has cautioned that the high rate of positive cases and the increasing number of infections and fatalities suggest the possibility of a significantly larger outbreak than what is currently being documented.
As of Sunday, the CDC reported over 300 suspected cases and 88 suspected deaths. The majority of these have occurred in Congo, with some cases also identified in neighboring Uganda. The specific strain of Ebola involved in this outbreak is known as Bundibugyo, a virus for which there is currently no vaccine or approved treatment. Historically, the Bundibugyo strain has demonstrated fatality rates ranging between 25% and 50%.
In response to the evolving situation, the CDC announced on Monday that it will implement entry restrictions into the United States for individuals without a U.S. passport who have recently traveled to the Democratic Republic of the Congo, South Sudan, or Uganda within the past three weeks. These restrictions will be in effect for the next 30 days.
Despite the absence of a specific vaccine or treatment for the Bundibugyo strain, CDC officials indicated on Monday that efforts are underway to develop a monoclonal antibody therapy. This therapy is being explored as a potential treatment option for individuals infected with this particular strain of Ebola.
